DK1338657T3 - Specifikt fra genomet af Mycobacterium tuberculosis-deleterede sekvenser og anvendelse heraf i diagnostik og som vacciner - Google Patents

Specifikt fra genomet af Mycobacterium tuberculosis-deleterede sekvenser og anvendelse heraf i diagnostik og som vacciner

Info

Publication number
DK1338657T3
DK1338657T3 DK02290458T DK02290458T DK1338657T3 DK 1338657 T3 DK1338657 T3 DK 1338657T3 DK 02290458 T DK02290458 T DK 02290458T DK 02290458 T DK02290458 T DK 02290458T DK 1338657 T3 DK1338657 T3 DK 1338657T3
Authority
DK
Denmark
Prior art keywords
mycobacterium
vaccines
diagnostics
genome
specifically
Prior art date
Application number
DK02290458T
Other languages
Danish (da)
English (en)
Inventor
Stewart Cole
Roland Brosch
Stephen Glyn Hewinson Gordon
Karin Eiglmeier
Thierry Garnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK1338657T3 publication Critical patent/DK1338657T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
DK02290458T 2002-02-25 2002-02-25 Specifikt fra genomet af Mycobacterium tuberculosis-deleterede sekvenser og anvendelse heraf i diagnostik og som vacciner DK1338657T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290458A EP1338657B9 (de) 2002-02-25 2002-02-25 Spezifisch vom Genom von Mycobacterium tuberculosis deletierte Sequenzen und deren Verwendung in der Diagnostik und als Vakzine

Publications (1)

Publication Number Publication Date
DK1338657T3 true DK1338657T3 (da) 2007-07-30

Family

ID=27635905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02290458T DK1338657T3 (da) 2002-02-25 2002-02-25 Specifikt fra genomet af Mycobacterium tuberculosis-deleterede sekvenser og anvendelse heraf i diagnostik og som vacciner

Country Status (12)

Country Link
US (1) US7977047B2 (de)
EP (2) EP1338657B9 (de)
JP (1) JP4738740B2 (de)
AT (2) ATE360097T1 (de)
AU (1) AU2003208539B2 (de)
CA (1) CA2477195C (de)
CY (1) CY1106584T1 (de)
DE (2) DE60219589T2 (de)
DK (1) DK1338657T3 (de)
ES (1) ES2286212T3 (de)
PT (1) PT1338657E (de)
WO (1) WO2003070981A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1350839E (pt) 2002-04-05 2010-08-12 Pasteur Institut Identificação de regiões rd1 e rd5 associadas a virulência que permitam o desenvolvimento de vacinas melhoradas de m. bovis bcg e m. microti
GB0406271D0 (en) 2004-03-19 2004-04-21 Isis Innovation Diagnostic test
US8044184B2 (en) 2004-04-26 2011-10-25 Wako Pure Chemical Industries, Ltd. Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US20080206776A1 (en) * 2005-09-05 2008-08-28 Bio-Rad Pasteur Use of Both Rd9 and Is6110 as Nucleic Acid Targets for the Diagnosis of Tuberculosis, and Provision of Multiplex-Compliant Is6110 and Rd9 Targets
BRPI0604958B1 (pt) * 2006-11-23 2022-05-17 Fundação Oswaldo Cruz Kit para distinção de mycobacterium tuberculosis, m. bovis, m. bovis bcg em uma amostra, e, método para distinguir mycobacterium tuberculosis, m. bovis, m. bovis bcg
WO2010132112A2 (en) * 2009-05-14 2010-11-18 Wisconsin Alumni Research Foundation Immunogenic compositions against tuberculosis
WO2012002598A1 (ko) * 2010-07-02 2012-01-05 (주)바이오니아 결핵 진단용 프라이머, 프로브, 이를 포함하는 키트 및 상기 키트를 이용한 결핵 진단 방법
JP2013055947A (ja) * 2012-10-26 2013-03-28 Bio-Rad Innovations 結核の診断のための核酸標的としてのｒｄ９およびｉｓ６１１０の使用、ならびにマルチプレックス−コンプライアントｉｓ６１１０およびｒｄ９標的の提供
ES2752761T3 (es) * 2014-07-24 2020-04-06 Abbott Molecular Inc Composiciones para la detección y análisis de mycobacterium tuberculosis
WO2017156436A1 (en) * 2016-03-11 2017-09-14 S&R Pharmaceuticals, Llc Assays and methods for detecting mycobacterial infections
CN106868113A (zh) * 2017-01-24 2017-06-20 中国疾病预防控制中心传染病预防控制所 用于鉴定牛型结核分枝杆菌的snp标记及其应用
WO2022235518A1 (en) * 2021-05-03 2022-11-10 The Board Of Trustees Of The Leland Stanford Junior University Method for diagnosing active tuberculosis and progression to active tuberculosis
KR20220164261A (ko) 2021-06-04 2022-12-13 (주)아모레퍼시픽 단백질 분해효소 안정성 증진용 조성물, 이를 포함하는 동결건조 조성물, 이를 포함하는 화장품 키트, 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
FR2791067B1 (fr) * 1999-03-16 2003-01-31 Pasteur Institut Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins
WO2001002555A1 (en) * 1999-07-06 2001-01-11 Institut Pasteur Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms

Also Published As

Publication number Publication date
EP1478777A2 (de) 2004-11-24
CY1106584T1 (el) 2012-01-25
AU2003208539B2 (en) 2008-11-20
EP1338657B9 (de) 2007-10-10
CA2477195A1 (en) 2003-08-28
JP4738740B2 (ja) 2011-08-03
AU2003208539A1 (en) 2003-09-09
WO2003070981A2 (en) 2003-08-28
WO2003070981A8 (en) 2004-10-07
WO2003070981A3 (en) 2003-12-04
EP1338657B1 (de) 2007-04-18
ATE360097T1 (de) 2007-05-15
PT1338657E (pt) 2007-06-21
ES2286212T3 (es) 2007-12-01
DE60219589D1 (de) 2007-05-31
CA2477195C (en) 2015-01-06
US7977047B2 (en) 2011-07-12
EP1338657A1 (de) 2003-08-27
JP2005518203A (ja) 2005-06-23
EP1478777B1 (de) 2008-08-06
US20060127897A1 (en) 2006-06-15
DE60219589T2 (de) 2008-02-14
DE60322674D1 (de) 2008-09-18
ATE403752T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DK1338657T3 (da) Specifikt fra genomet af Mycobacterium tuberculosis-deleterede sekvenser og anvendelse heraf i diagnostik og som vacciner
Pallen et al. High-throughput sequencing and clinical microbiology: progress, opportunities and challenges
NO20091051L (no) Renseprosess for montelukast og dets aminsalter
ES2157230T3 (es) Deteccion de mycobacteria por amplificacion multiple de acidos nucleicos.
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
DK2103694T3 (da) Materialer og fremgangsmåder til indfangning af patogener og fjernelse af aurintricarboxylsyre fra en prøve
JP2012528567A5 (de)
SE0301951D0 (sv) New method
WO2009024822A3 (en) Diagnostic method and kit
JP2017521086A5 (de)
WO2020127908A3 (en) Method of detecting infection with pathogens causing tuberculosis
WO2009051776A3 (en) Methods for detecting and differentiating mycobacterium genus and mycobacterium avium complex in a sample or culture
Amoudy et al. Identification of transcriptionally active open reading frames within the RD1 genomic segment of Mycobacterium tuberculosis
ATE431432T1 (de) Verfahren zum nachweis von mycobacterium tuberculosis
Viale et al. The genomics of mycobacteria
DK1567668T3 (da) Detektion, identificering og differentiering af eubakterielle taxa ved anvendelse af et hybridiseringsassay
ATE518964T1 (de) Verfahren und kit zum spezifischen nachweis von m. tuberculosis
ATE548465T1 (de) Diagnoseverfahren und dafür geeignete produkte
JP2015039361A (ja) 唾液の細菌叢の解析方法
RU2011120790A (ru) Способ диагностики коклюша и определения авирулентных мутантов возбудителя и диагностический набор
RU2016129359A (ru) Способ выделения ДНК клинических изолятов Mycobacterium tuberculosis из ткани легкого
WO2004104170A3 (en) Tools for detecting moraxella catarrhalis.
Lin et al. Longitudinal accumulation of in vivo and in vitro-grown Treponema pallidum subsp. pallidum TprK variants in the presence and absence of immune pressure
ATE486138T1 (de) Verfahren zum nachweis von bakterien der gattung mycobacterium (säureresistente bakterien)
Krysztopa-Grzybowska et al. PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases